Evidence map›Paper›PMID 35159143›Full record

ArticleCells2022

Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.

Gabriele Roccuzzo, Silvia Giordano, Gianluca Avallone, Marco Rubatto, Silvia Canonico, Ada Funaro, Erika Ortolan, Rebecca Senetta, Paolo Fava, Maria Teresa Fierro and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Gabriele RoccuzzoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Silvia GiordanoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Gianluca AvalloneSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0001-7253-2370
Marco RubattoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0003-1706-656X
Silvia CanonicoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Ada FunaroLaboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0001-6341-1817
Erika OrtolanLaboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0003-2287-9020
Rebecca SenettaPathology Unit, Department of Oncology, University of Turin, 10126 Torino, Italy.
Paolo FavaSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Maria Teresa FierroSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Simone RiberoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Pietro QuaglinoSection of Dermatology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sézary syndrome is a rare subtype of cutaneous T-cell lymphoma characterized by erythroderma, peripheral lymphadenopathies, and circulating atypical cerebriform T-cells. To date, no definite staging system has been developed for these patients. In this retrospective analysis of the archive of the Dermatological Clinic of the University of Turin, Italy, erythrodermic SS patients were classified according to clinical records and photographs into three main presentations: erythematous, infiltrated, or melanodermic. The pattern of erythroderma was found to be associated with disease outcome, as better survivals were recorded in patients with erythematous and infiltrative erythroderma. Patients in the melanodermic group, though less represented in our investigation, seemed to show a worse trend in survival. According to this preliminary evidence, a new prognostic classification, with a revised score specific for Sézary syndrome patients, can be proposed to usefully integrate the current staging system. The correlation displayed in our research will be hopefully confirmed by prospective studies with larger cohorts, with the aim of identifying significant prognostic features in this subset of cutaneous T-cell lymphoma patients.

Indexed as

Dermatitis, ExfoliativeLymphoma, T-Cell, CutaneousMycosis FungoidesSezary SyndromeSkin NeoplasmsHumansProspective StudiesRetrospective StudiesCTCLcutaneous lymphomaerythrodermicmycosis fungoidesSézary syndrome

Identifiers

PMID35159143
PMCPMC8834570
OpenAlexW4206998645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.